Nanjing Leads Biolabs Co., Ltd., is a clinical-stage R&D biotech company founded in Nanjing by a senior research and development team of antibody therapies in the United States. Our company is dedicated to researching and developing novel antibody-based therapeutics in oncology and immunological disease areas to address global unmet needs of patients. We already have a rich R&D pipeline consisting of more than ten innovative cancer immunotherapy antibody projects on the monoclonal antibody and bispecific antibody development technology platform. The company will continue to expand innovation, to provide patients with safe, effective, accessible and affordable new drugs to meet unmet medical needs.

Philosophy: care for life, focus on innovation, win-win cooperation.

Vision and mission: Our mission is to become a fully integrated leading biopharmaceutical company, to provide safe, effective and affordable therapeutic antibodies for patients worldwide to meet global unmet medical needs.

Values: innovation, dedication, integrity, practice